Schaniel C, Pardali E, Sallusto F, Speletas M, Ruedl C, Shimizu T, Seidl T, Andersson J, Melchers F, Rolink A G, Sideras P
Basel Institute for Immunology, CH-4005, Basel, Switzerland.
J Exp Med. 1998 Aug 3;188(3):451-63. doi: 10.1084/jem.188.3.451.
Genes were isolated using the suppression subtractive hybridization method by stimulation of pro/pre B cells with anti-CD40 and interleukin (IL)-4 to mature S mu-Sepsilon-switched cells. One of the strongly upregulated genes encodes a novel murine CC chemokine we have named ABCD-1. The ABCD-1 gene has three exons separated by 1. 2- and 2.7-kb introns. It gives rise to a 2.2-kb transcript containing an open reading frame of 276 nucleotides. Two polyadenylation sites are used, giving rise to cDNAs with either 1550 or 1850 bp of 3' untranslated regions. The open reading frame encodes a 24 amino acid-long leader peptide and a 68 amino acid-long mature protein with a predicted molecular mass of 7.8 kD. ABCD-1 mRNA is found in highest quantities in activated splenic B lymphocytes and dendritic cells. Little chemokine mRNA is present in lung, in unstimulated splenic cells, in thymocytes, and in lymph node cells. No ABCD-1 mRNA is detected in bone marrow, liver, kidney, or brain, in peritoneal exudate cells as well as in the majority of all unstimulated B lineage cells tested. It is also undetectable in Concanavalin A-activated/IL-2-restimulated splenic T cells, and in bone marrow-derived IL-2-induced natural killer cells and IL-3-activated macrophages. Recombinant ABCD-1 revealed a concentration-dependent and specific migration of activated splenic T lymphoblasts in chemotaxis assays. FACS(R) analyses of migrated cells showed no preferential difference in migration of CD4(+) versus CD8(+) T cell blasts. Murine as well as human T cells responded to ABCD-1. Freshly isolated cells from bone marrow, thymus, spleen, and lymph node, IL-2-activated NK cells, and LPS-stimulated splenic cells, all did not show any chemotactic response. Thus, ABCD-1 is the first chemokine produced in large amounts by activated B cells and acting selectively on activated T lymphocytes. Therefore, ABCD-1 is expected to play an important role in the collaboration of dendritic cells and B lymphocytes with T cells in immune responses.
通过用抗CD40和白细胞介素(IL)-4刺激前B细胞/前B细胞使其成熟为Sμ-Sε转换细胞,使用抑制性消减杂交方法分离基因。其中一个强烈上调的基因编码一种新型小鼠CC趋化因子,我们将其命名为ABCD-1。ABCD-1基因有三个外显子,由1.2 kb和2.7 kb的内含子隔开。它产生一个2.2 kb的转录本,包含一个276个核苷酸的开放阅读框。使用了两个聚腺苷酸化位点,产生了3'非翻译区为1550或1850 bp的cDNA。开放阅读框编码一个24个氨基酸长的前导肽和一个68个氨基酸长的成熟蛋白,预测分子量为7.8 kD。在活化的脾B淋巴细胞和树突状细胞中发现ABCD-1 mRNA的含量最高。在肺、未刺激的脾细胞、胸腺细胞和淋巴结细胞中存在少量趋化因子mRNA。在骨髓、肝脏、肾脏或大脑、腹腔渗出细胞以及大多数测试的未刺激B谱系细胞中未检测到ABCD-1 mRNA。在伴刀豆球蛋白A活化/IL-2再刺激脾T细胞、骨髓来源的IL-2诱导的自然杀伤细胞和IL-3活化的巨噬细胞中也检测不到。重组ABCD-1在趋化性测定中显示活化的脾T淋巴母细胞有浓度依赖性和特异性迁移。对迁移细胞的荧光激活细胞分选(FACS)分析显示,CD4(+)与CD8(+) T细胞母细胞的迁移没有优先差异。小鼠和人类T细胞对ABCD-1有反应。从骨髓、胸腺、脾脏和淋巴结新鲜分离的细胞、IL-2活化的NK细胞和LPS刺激的脾细胞,均未显示任何趋化反应。因此,ABCD-1是活化B细胞大量产生并选择性作用于活化T淋巴细胞的首个趋化因子。因此,预计ABCD-1在免疫反应中树突状细胞和B淋巴细胞与T细胞的协作中发挥重要作用。